Two approaches to tackling COVID-19 in patients with blood cancer
Two approaches to tackling COVID-19 in patients with blood cancer
Patients with blood cancer have fewer antibodies after SARS-CoV-2 vaccination — but recent work shows that these antibodies seem to bind to viral spike protein more strongly than those in matched controls. In addition, another study finds that convalescent or vaccinee plasma might improve COVID-19 outcomes in those with blood cancer.
5-6
Wijaya, Ratna
03dbd605-74df-4a5b-ad44-d04f7b17f5f4
Lim, Sean H.
1afe5aa1-61a4-4a7b-927f-5e671f885196
31 January 2023
Wijaya, Ratna
03dbd605-74df-4a5b-ad44-d04f7b17f5f4
Lim, Sean H.
1afe5aa1-61a4-4a7b-927f-5e671f885196
Wijaya, Ratna and Lim, Sean H.
(2023)
Two approaches to tackling COVID-19 in patients with blood cancer.
Nature Cancer, 4 (1), .
(doi:10.1038/s43018-022-00505-8).
Abstract
Patients with blood cancer have fewer antibodies after SARS-CoV-2 vaccination — but recent work shows that these antibodies seem to bind to viral spike protein more strongly than those in matched controls. In addition, another study finds that convalescent or vaccinee plasma might improve COVID-19 outcomes in those with blood cancer.
Text
Wijaya_et_al-2023-Nature_Cancer
- Version of Record
Restricted to Repository staff only
Request a copy
More information
Published date: 31 January 2023
Identifiers
Local EPrints ID: 475111
URI: http://eprints.soton.ac.uk/id/eprint/475111
ISSN: 2662-1347
PURE UUID: 222791ff-56bb-46a3-95a9-974a3a822ab3
Catalogue record
Date deposited: 10 Mar 2023 17:32
Last modified: 12 Dec 2024 02:43
Export record
Altmetrics
Contributors
Author:
Ratna Wijaya
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
